Homeβ€ΊSearchβ€ΊDrugs - Real World Outcomes

Drugs - Real World Outcomes

Springer International Publishing AG Β· Switzerland Β· Est. 1990

ISSN2199-1154eISSN2198-9788
SJR Q2βœ“ WOS ESCIβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
88
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† Scopus Q266
βœ“ Corroboration (4 more)+22
Total88
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
8
weeks to publish Β· journal-reported
Fast Β· vs ~15 wk median
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (ESCI) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.662
H-Indexi
32
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.733
Total Worksi
541
Total Citationsi
5,426
2yr Mean Citednessi
2.04
Open Impact Factor alternative

Aims & Scope

Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas: Using registries/databases/health records and other non-selected observational datasets to investigate: drug use and treatment outcomes prescription patterns drug safety signals adherence to treatment guidelines benefit : risk profiles comparative effectiveness economic analyses including cost-of-illness Data-driven research methodologies, including the capture, curation, search, sharing, analysis and interpretation of β€˜big data’ Techniques and approaches to optimise real-world modelling.

General Information

Country / RegionSwitzerland
Primary LanguageEnglish
1st Year Published1990
FrequencyQuarterly
StatusActive (last: 2026)
Total Publications541
Publisher OrgAdis, Springer Healthcare
OA Since2013
Visit Journal Website

Submission Info

Peer ReviewSingle-blind
Review Time~8 weeks
Acceptance Rateβ€”
OA LicenseCC BY-NC
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
PorticoPMCCLOCKSS

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
Springer International Publishing AG
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2199-1154 / 2198-9788
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
βœ…
Peer review process documented?
Single-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
Portico, PMC, CLOCKSS
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
30
646
2019
45
577
2020
61
740
2021
60
590
2022
61
317
2023
63
279
2024
61
60
2025
29
4
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

Pharmacology (medical)

Research Topics (OpenAlex)

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical Practices and Patient OutcomesMedication Adherence and ComplianceHeart Failure Treatment and ManagementRheumatoid Arthritis Research and TherapiesAntibiotic Use and ResistanceSchizophrenia research and treatmentAtrial Fibrillation Management and OutcomesOpioid Use Disorder TreatmentDiabetes Treatment and Management

Frequently asked questions about Drugs - Real World Outcomes

Is Drugs - Real World Outcomes a predatory journal?

PubScope has no integrity flags on record for Drugs - Real World Outcomes: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 88/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Drugs - Real World Outcomes?

Drugs - Real World Outcomes is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.04.

Is Drugs - Real World Outcomes indexed in Scopus and Web of Science?

Drugs - Real World Outcomes is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Drugs - Real World Outcomes?

Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas: Using registries/databases/health records and other non-selected observational datasets to investigate: drug use and treatment outcomes prescription patterns drug safety signals adherence to treatment guidelines benefit : risk profiles comparative effectiveness economic analyses i

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref